Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin vs. BEP in Advanced or Recurrent Ovarian Sex Cord-Stromal Tumors
NCT01042522Phase 2Unknown
- Sponsor
- GOG Foundation
- Start
- Feb 2010
- Primary completion
- Jun 2020
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in Ovarian sex-cord stromal tumor (SCST), sponsored by GOG Foundation. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
Ovarian sex-cord stromal tumor (SCST)
Beyond the preview
Go deeper on NCT01042522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042522.